NCT02309671View on ClinicalTrials.gov

A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

September 30, 2016

Conditions
Infertility
Interventions
DRUG

FE 999049

DRUG

follitropin beta

Trial Locations (1)

Unknown

Investigational site (there may be other sites in this country), Tokyo

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY